Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction have?
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction has 2,383 citations in the OpenAlex counts ScholarIQ stores.
When was Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction published?
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction has 2019 year in the ScholarIQ index.
What is the open-access status of Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction?
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction has bronze oa status in the ScholarIQ index.
What is the DOI of Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction?
The DOI for Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction is on the source record.
What is the PMID of Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction?
The PMID for Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction is on the source record.
What is the OpenAlex record for Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction?
The OpenAlex for Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction is on the source record.